Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Gross Profit | -1,711 | -20,311 | -31,554 | -23,937 | -23,870 |
| Selling General And Administration | 157,728 | 200,033 | 117,891 | 116,093 | 772,181 |
| General And Administrative Expense | 157,728 | 200,033 | 117,891 | 116,093 | 772,181 |
| Research And Development | -- | -- | 0.00 | 0.00 | 0.00 |
| Other Operating Expenses | 301,372 | 309,834 | 324,505 | 163,114 | 248,811 |
| Operating Expense | 459,100 | 509,867 | 442,396 | 279,207 | 1.0M |
| Operating Income | -460,811 | -530,178 | -473,950 | -303,144 | -1.0M |
| EBIT | -460,811 | -530,178 | -473,950 | -303,144 | -1.0M |
| Interest Income | 8,131 | 12,320 | 15,047 | 12,186 | 16,855 |
| Interest Income Non Operating | 8,131 | 12,320 | 15,047 | 12,186 | 16,855 |
| Net Interest Income | 8,131 | 12,320 | 15,047 | 12,186 | 16,855 |
| Other Income Expense | -58,005 | -99,636 | 70,051 | -2.2M | -115,973 |
| Other Non Operating Income Expenses | 18,894 | 5,953 | -- | -- | -- |
| Special Income Charges | 0.00 | 8,661 | 0.00 | -2.1M | 0.00 |
| Write Off | -- | -- | 0.00 | 0.00 | -- |
| Gain On Sale Of Security | 1,100 | -7,519 | -2,643 | 1,230 | 2,654 |
| Earnings From Equity Interest | -77,999 | -106,731 | 72,694 | -42,676 | -118,627 |
| Pretax Income | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Income From Continuing Operation Net Minority Interest | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Income Including Noncontrolling Interests | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Income Common Stockholders | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Income | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| EBITDA | -459,100 | -509,867 | -442,396 | -279,207 | -1.0M |
| Normalized EBITDA | -460,200 | -511,009 | -439,753 | 1.9M | -1.0M |
| Reconciled Depreciation | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Basic Average Shares | 248.9M | 217.2M | 223.9M | 219.6M | 212.6M |
| Diluted Average Shares | 248.9M | 217.2M | 223.9M | 219.6M | 212.6M |
| Total Unusual Items | 1,100 | 1,142 | -2,643 | -2.1M | 2,654 |
| Total Unusual Items Excluding Goodwill | 1,100 | 1,142 | -2,643 | -2.1M | 2,654 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -511,785 | -618,636 | -386,209 | -333,634 | -1.1M |
| Diluted NI Availto Com Stockholders | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Gain On Sale Of Ppe | 0.00 | 8,661 | -- | -- | -- |
| Impairment Of Capital Assets | 0.00 | -- | 0.00 | 2.1M | -- |
| Net Income Continuous Operations | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Non Operating Interest Income Expense | 8,131 | 12,320 | 15,047 | 12,186 | 16,855 |
| Other Gand A | 138,622 | 121,966 | 41,175 | 21,949 | 39,590 |
| Reconciled Cost Of Revenue | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Salaries And Wages | 19,106 | 78,067 | 76,716 | 94,144 | 732,591 |
| Total Expenses | 460,811 | 530,178 | 473,950 | 303,144 | 1.0M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 560,717 | 1.2M | 636,654 | 1.1M | 1.1M |
| Cash Cash Equivalents And Short Term Investments | 560,717 | 1.2M | 636,654 | 1.1M | 1.1M |
| Accounts Receivable | 130,567 | 148,573 | 89,616 | 245,070 | 37,700 |
| Receivables | 237,177 | 236,770 | 172,745 | 310,428 | 184,032 |
| Inventory | 456,643 | 447,569 | 473,249 | 454,403 | 463,239 |
| Prepaid Assets | 65,944 | 99,632 | 146,011 | 303,931 | 229,601 |
| Current Assets | 1.3M | 2.0M | 1.4M | 2.2M | 2.0M |
| Gross PPE | 9.2M | 8.6M | 9.3M | 8.6M | 10.7M |
| Accumulated Depreciation | -2.0M | -1.9M | -2.6M | -2.4M | -2.4M |
| Net PPE | 7.2M | 6.7M | 6.7M | 6.2M | 8.2M |
| Investments And Advances | 13.9M | 13.9M | 14.3M | 14.2M | 14.2M |
| Long Term Equity Investment | 13.9M | 13.9M | 14.3M | 14.2M | 14.2M |
| Total Non Current Assets | 21.1M | 20.6M | 21.0M | 20.4M | 22.5M |
| Total Assets | 22.4M | 22.6M | 22.4M | 22.6M | 24.5M |
| Payables And Accrued Expenses | 571,125 | 398,558 | 270,423 | 445,843 | 273,120 |
| Current Liabilities | 571,125 | 398,558 | 270,423 | 445,843 | 273,120 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 571,125 | 398,558 | 270,423 | 445,843 | 273,120 |
| Common Stock | 53.9M | 53.9M | 52.2M | 52.2M | 51.7M |
| Capital Stock | 53.9M | 53.9M | 52.2M | 52.2M | 51.7M |
| Retained Earnings | -40.0M | -39.5M | -38.0M | -37.6M | -35.2M |
| Gains Losses Not Affecting Retained Earnings | 1.1M | 924,474 | 1.1M | 770,286 | 875,801 |
| Other Equity Adjustments | 1.1M | 924,474 | 1.1M | 770,286 | 875,801 |
| Common Stock Equity | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Stockholders Equity | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Total Equity Gross Minority Interest | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Total Capitalization | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Net Tangible Assets | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Tangible Book Value | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Working Capital | 749,356 | 1.6M | 1.2M | 1.7M | 1.7M |
| Invested Capital | 21.9M | 22.2M | 22.1M | 22.1M | 24.2M |
| Share Issued | 248.9M | 248.9M | 223.9M | 223.9M | 216.7M |
| Ordinary Shares Number | 248.9M | 248.9M | 223.9M | 223.9M | 216.7M |
| Investmentsin Associatesat Cost | 13.9M | 13.9M | 14.3M | 14.2M | 14.2M |
| Land And Improvements | 278,163 | 272,608 | 438,496 | 411,373 | 417,103 |
| Other Equity Interest | 6.9M | 6.9M | 6.8M | 6.8M | 6.8M |
| Raw Materials | 456,643 | 447,569 | 473,249 | 454,403 | 463,239 |
| Taxes Receivable | 106,610 | 88,197 | 83,129 | 65,358 | 146,332 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -226,799 | -372,586 | -294,261 | -395,751 | -360,002 |
| Cash Flow From Continuing Operating Activities | -226,799 | -372,586 | -294,261 | -395,751 | -360,002 |
| Depreciation And Amortization | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Depreciation Amortization Depletion | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Stock Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 636,155 |
| Change In Working Capital | 204,176 | 126,527 | 135,731 | -129,960 | 5,326 |
| Changes In Account Receivables | 20,998 | -56,420 | 165,603 | -208,840 | 45,712 |
| Change In Receivables | 4,283 | -63,644 | 152,952 | -129,170 | 42,337 |
| Change In Inventory | 46.00 | 66.00 | 10,603 | 2,492 | 332.00 |
| Change In Payables And Accrued Expense | 165,310 | 173,653 | -192,872 | 74,375 | -41,360 |
| Capital Expenditure | -472,705 | -67,976 | -135,878 | -196,069 | -246,181 |
| Purchase Of PPE | -- | -67,976 | 0.00 | 432,458 | -246,181 |
| Net PPE Purchase And Sale | 67,976 | -44,465 | 0.00 | 432,458 | -246,181 |
| Purchase Of Investment | -- | -- | 0.00 | -- | -- |
| Net Investment Purchase And Sale | -- | -- | 0.00 | -- | -- |
| Investing Cash Flow | -472,705 | -44,465 | -135,878 | -196,069 | -246,181 |
| Cash Flow From Continuing Investing Activities | -472,705 | -44,465 | -135,878 | -196,069 | -246,181 |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 669,874 | 1.5M |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 669,874 | 1.5M |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 666,375 | 1.3M |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 0.00 | 666,375 | 1.3M |
| Effect Of Exchange Rate Changes | 50,587 | 14,840 | -47,575 | -92,182 | 96,084 |
| Changes In Cash | -699,504 | -417,051 | -430,139 | 74,555 | 725,785 |
| Beginning Cash Position | 1.2M | 1.6M | 1.1M | 1.1M | 310,126 |
| End Cash Position | 560,717 | 1.2M | 636,654 | 1.1M | 1.1M |
| Free Cash Flow | -699,504 | -440,562 | -430,139 | -591,820 | -606,183 |
| Asset Impairment Charge | -- | -- | 0.00 | -- | -- |
| Capital Expenditure Reported | -- | -- | -135,878 | -- | -- |
| Change In Prepaid Assets | 34,537 | 16,452 | 165,048 | -77,657 | 4,017 |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 669,874 | 1.5M |
| Depreciation | 1,711 | 20,311 | 31,554 | 23,937 | 23,870 |
| Earnings Losses From Equity Investments | 77,999 | 106,731 | -72,694 | 42,676 | 118,627 |
| Gain Loss On Sale Of PPE | 0.00 | -8,661 | -- | -- | -- |
| Net Income From Continuing Operations | -510,685 | -617,494 | -388,852 | -2.5M | -1.1M |
| Net Other Financing Charges | -- | -- | 0.00 | -3,499 | -198,032 |
| Operating Gains Losses | 77,999 | 98,070 | -72,694 | 42,676 | 118,627 |
| Sale Of PPE | 0.00 | 23,511 | -- | -- | -- |